NEPHRON PHARMACEUTICALS CORPORATION Trademark

Trademark Overview

On Monday, August 29, 2011, a trademark application was filed for NEPHRON PHARMACEUTICALS CORPORATION with the United States Patent and Trademark Office. The USPTO has given the NEPHRON PHARMACEUTICALS CORPORATION trademark a serial number of 85409595. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, November 7, 2022. This trademark is owned by Nephron Pharmaceuticals Corporation. The NEPHRON PHARMACEUTICALS CORPORATION trademark is filed in the Pharmaceutical Products category with the following description:

Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders
nephron pharmaceuticals corporation

General Information

Serial Number85409595
Word MarkNEPHRON PHARMACEUTICALS CORPORATION
Filing DateMonday, August 29, 2011
Status800 - REGISTERED AND RENEWED
Status DateMonday, November 7, 2022
Registration Number4263237
Registration DateTuesday, December 25, 2012
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 27, 2012

Trademark Statements

Description of MarkThe mark consists of the phrase "nephron pharmaceuticals corporation" next to a design comprising beakers.
Goods and ServicesInhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICALS CORPORATION"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 1, 2011
Primary Code005
First Use Anywhere DateTuesday, September 30, 1997
First Use In Commerce DateTuesday, September 30, 1997

Trademark Owner History

Party NameNephron Pharmaceuticals Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWest Columbia, SC 29172
Party NameNephron Pharmaceuticals Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOrlando, FL 32811
Party NameNephron Pharmaceuticals Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOrlando, FL 32811

Trademark Events

Event DateEvent Description
Monday, November 7, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, November 7, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, November 7, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, November 7, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 16, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 16, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 16, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 6, 2022TEAS SECTION 8 & 9 RECEIVED
Saturday, December 25, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, August 8, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, August 8, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, August 8, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 25, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, December 25, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, August 13, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, December 25, 2012REGISTERED-PRINCIPAL REGISTER
Thursday, November 15, 20121(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, November 15, 2012NOTICE OF ALLOWANCE CANCELLED
Tuesday, November 13, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 9, 2012TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, May 22, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 27, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 27, 2012PUBLISHED FOR OPPOSITION
Wednesday, March 7, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 17, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, February 16, 2012ASSIGNED TO LIE
Wednesday, February 1, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 1, 2012EXAMINER'S AMENDMENT ENTERED
Wednesday, February 1, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 1, 2012EXAMINERS AMENDMENT E-MAILED
Wednesday, February 1, 2012EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 1, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 1, 2012NON-FINAL ACTION E-MAILED
Wednesday, February 1, 2012NON-FINAL ACTION WRITTEN
Saturday, January 21, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 20, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 20, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 16, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 16, 2011NON-FINAL ACTION E-MAILED
Friday, December 16, 2011NON-FINAL ACTION WRITTEN
Friday, December 16, 2011ASSIGNED TO EXAMINER
Friday, September 2, 2011NOTICE OF DESIGN SEARCH CODE MAILED
Thursday, September 1, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 1, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

corporation pharmaceuticals nephron diseases disorders respiratory treatment pharmaceutical preparations inhaled